When a study says participants were “randomized,” that word is doing less work than most readers assume. Randomization actually involves two separate protections against bias: generating a random sequence for assigning participants to groups, and concealing that sequence from everyone involved until each participant is enrolled. A trial can get the first one right and still fail the second, and the word “randomized” alone will not tell you which happened.
The Short Answer
Random sequence generation is the method used to decide, by chance, which group each participant will be assigned to (for example, a computer-generated random number list). Allocation concealment is a separate, later step: keeping that sequence hidden from the people enrolling participants and the participants themselves, so no one can predict or influence which group the next person will land in. One is about how the sequence was built. The other is about whether anyone could see it coming.
Two Different Jobs, Two Different Failure Points
Think of these as two rungs on the same ladder. Each one protects against a different way a trial can go wrong, and climbing one rung does not mean the other has been climbed.
Rung 1: Generating the Sequence
This is the mechanism that introduces chance into group assignment. Common approaches include:
- Simple (unrestricted) randomization — each assignment is independent, similar to a coin flip for each participant.
- Blocked randomization — assignments are balanced within small blocks of participants so group sizes stay roughly equal throughout enrollment.
- Stratified randomization — randomization is performed separately within subgroups (such as by study site or disease severity) to keep those characteristics balanced between groups.
A sequence generated this way is unpredictable in principle. But knowing the method used to build the list says nothing about what happened to that list afterward.
Rung 2: Concealing the Sequence
Once a sequence exists, someone has to enroll participants without knowing in advance which group each new participant will join. This is what allocation concealment protects against. Methods that support strong concealment include:
- Central randomization — enrollment staff contact a separate phone or web-based system that reveals the assignment only after a participant is confirmed eligible and enrolled.
- Pharmacy-controlled allocation — a pharmacy or independent unit not involved in enrollment holds and dispenses the assignment.
- Sequentially numbered, opaque, sealed envelopes — a lower-tech method that can work if opened strictly in order and not held up to light.
Concealment can fail even with proper randomization. Cochrane’s guidance on assessing randomized trials notes that unsealed or translucent envelopes have been compromised in practice, and that predictable block sizes can let enrolling staff anticipate upcoming assignments, particularly late in a block. When concealment fails, staff can consciously or unconsciously steer certain participants toward or away from a given group, which reintroduces the kind of selection bias randomization was supposed to eliminate.
What “Randomized” Alone Doesn’t Tell You
A trial report that simply states “participants were randomly assigned” has told you about sequence generation, or possibly nothing verifiable at all if no method is described. It has not told you:
- Whether the people enrolling participants could see or predict upcoming assignments.
- Whether the concealment method could be defeated (for example, by holding an envelope up to light).
- Whether block size or site-level patterns made late assignments in a block predictable.
This is why reporting guidelines for trials, such as the CONSORT and SPIRIT statements, ask authors to describe sequence generation and allocation concealment as two separate reporting items rather than folding them into one line about “randomization.” A complete trial report should let a reader evaluate each step independently.
What We Know vs. What Remains Unclear
Established:
- Random sequence generation and allocation concealment are distinct methodological steps that protect against different sources of bias.
- Successful allocation concealment can always be implemented in a trial, regardless of the clinical area or design, because it only requires hiding a sequence, not hiding treatment identity after assignment (which is blinding, a separate and later step).
- Poor or absent concealment has been linked to selective enrollment problems in real trials, based on documented cases in the methodological literature.
Often unclear from a published report:
- Many trial reports describe randomization in general terms without specifying the concealment method used, which limits how confidently a reader can assess this domain.
- Whether a stated concealment method (such as sealed envelopes) was followed correctly in practice is rarely verifiable from the published report alone.
A Practical Checklist for Reading a Trial Report
If you’re new to reading trial methods sections at all, our guide on how to read a clinical study walks through the full report structure first. From there, apply this checklist to the randomization details specifically:
- Look in the methods section for a specific sequence generation method (computer-generated, random number table, etc.), not just the word “randomized.”
- Separately look for a specific allocation concealment method (central randomization, pharmacy control, sealed opaque envelopes).
- If neither is described, treat this as missing information rather than assuming best practice was followed.
- Note whether the trial used blocked randomization and, if so, whether block size was fixed or varied, since fixed small blocks are easier to predict.
- Remember that concealment and blinding are different: concealment protects enrollment before assignment, blinding protects against bias after assignment. A trial can conceal allocation well and still be unblinded, or vice versa.
Where to Go Next
For a broader look at how randomized controlled trials work and where they sit relative to other study designs, see our guide on randomized controlled trials explained. For an overview of how different study types compare more generally, see understanding clinical study design types.
Educational Disclaimer
This article is for general educational purposes only and explains research methodology; it does not provide medical advice, diagnosis, or treatment recommendations. It is not a substitute for professional medical judgment. Always talk with a qualified healthcare provider about your own health decisions.
By ClinicalStudyConnect.com Research Desk | Updated September 2026
The information in this article is based on peer-reviewed research, published clinical studies, and guidance from recognized health organizations including the National Institutes of Health (NIH) and the FDA. Individual results and experiences may vary.